Basic & Clinical Pharmacology, 14e (Record no. 1557)

MARC details
000 -LEADER
fixed length control field 06859nam a2200481 a 4500
001 - CONTROL NUMBER
control field scn00350103
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20210413150554.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m|||||||||||||||||
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr||n||||||||n
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 171226s2018||||nyu|||||s|||||||||||eng||
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781259641152 (printISBN)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1259641155 (print-ISBN)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1015240036
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM301.28
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 4
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1
Edition number 23
245 00 - TITLE STATEMENT
Title Basic & Clinical Pharmacology, 14e
Medium [electronic resource] /
Statement of responsibility, etc. [edited by] Bertram G Katzung.
246 30 - VARYING FORM OF TITLE
Title proper/short title Basic & Clinical Pharmacology, Fourteenth Edition
250 ## - EDITION STATEMENT
Edition statement 14th ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. New York, N.Y. :
Name of publisher, distributor, etc. McGraw-Hill Education LLC.,
Date of publication, distribution, etc. c2018.
300 ## - PHYSICAL DESCRIPTION
Extent xi, 1250 p. :
Other physical details ill., figs., tables.
490 1# - SERIES STATEMENT
Series statement McGraw-Hill's AccessPharmacy
490 1# - SERIES STATEMENT
Series statement A Lange medical book
500 ## - GENERAL NOTE
General note "A Lange medical book."
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and indexes.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note SECTION I: BASIC PRINCIPLES -- Chapter 1: Introduction: The Nature of Drugs & Drug Development & Regulation -- Chapter 2: Drug Receptors & Pharmacodynamics -- Chapter 3: Pharmacokinetics & Pharmacodynamics: Rational Dosing & the Time Course of Drug Action -- Chapter 4: Drug Biotransformation -- Chapter 5: Pharmacogenomics -- SECTION II: AUTONOMIC DRUGS -- Chapter 6: Introduction to Autonomic Pharmacology -- Chapter 7: Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs -- Chapter 8: Cholinoceptor-Blocking Drugs -- Chapter 9: Adrenoceptor Agonists & Sympathomimetic Drugs -- Chapter 10: Adrenoceptor Antagonist Drugs -- SECTION III: CARDIOVASCULAR-RENAL DRUGS -- Chapter 11: Antihypertensive Agents -- Chapter 12: Vasodilators & the Treatment of Angina Pectoris -- Chapter 13: Drugs Used in Heart Failure -- Chapter 14: Agents Used in Cardiac Arrhythmias -- Chapter 15: Diuretic Agents -- SECTION IV: DRUGS WITH IMPORTANT ACTIONS ON SMOOTH MUSCLE -- Chapter 16: Histamine, Serotonin, & the Ergot Alkaloids -- Chapter 17: Vasoactive Peptides -- Chapter 18: The Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, & Related Compounds -- Chapter 19: Nitric Oxide -- Chapter 20: Drugs Used in Asthma -- SECTION V: DRUGS THAT ACT IN THE CENTRAL NERVOUS SYSTEM -- Chapter 21: Introduction to the Pharmacology of CNS Drugs -- Chapter 22: Sedative-Hypnotic Drugs -- Chapter 23: The Alcohols -- Chapter 24: Antiseizure Drugs -- Chapter 25: General Anesthetics -- Chapter 26: Local Anesthetics -- Chapter 27: Skeletal Muscle Relaxants -- Chapter 28: Pharmacologic Management of Parkinsonism & Other Movement Disorders -- Chapter 29: Antipsychotic Agents & Lithium -- Chapter 30: Antidepressant Agents -- Chapter 31: Opioid Agonists & Antagonists -- Chapter 32: Drugs of Abuse -- SECTION VI: DRUGS USED TO TREAT DISEASES OF THE BLOOD, INFLAMMATION, & GOUT -- Chapter 33: Agents Used in Cytopenias; Hematopoietic Growth Factors -- Chapter 34: Drugs Used in Disorders of Coagulation -- Chapter 35: Agents Used in Dyslipidemia -- Chapter 36: Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics, & Drugs Used in Gout -- SECTION VII: ENDOCRINE DRUGS -- Chapter 37: Hypothalamic & Pituitary Hormones -- Chapter 38: Thyroid & Antithyroid Drugs -- Chapter 39: Adrenocorticosteroids & Adrenocortical Antagonists -- Chapter 40: The Gonadal Hormones & Inhibitors -- Chapter 41: Pancreatic Hormones & Antidiabetic Drugs -- Chapter 42: Agents That Affect Bone Mineral Homeostasis -- SECTION VIII: CHEMOTHERAPEUTIC DRUGS -- Section VIII: Chemotherapeutic Drugs: Introduction -- Chapter 43: Beta-Lactam & Other Cell Wall- & Membrane-Active Antibiotics -- Chapter 44: Tetracyclines, Macrolides, Clindamycin, Chloramphenicol, Streptogramins, & Oxazolidinones -- Chapter 45: Aminoglycosides & Spectinomycin -- Chapter 46: Sulfonamides, Trimethoprim, & Quinolones -- Chapter 47: Antimycobacterial Drugs -- Chapter 48: Antifungal Agents -- Chapter 49: Antiviral Agents -- Chapter 50: Miscellaneous Antimicrobial Agents; Disinfectants, Antiseptics, & Sterilants
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Chapter 51: Clinical Use of Antimicrobial Agents -- Chapter 52: Antiprotozoal Drugs -- Chapter 53: Clinical Pharmacology of the Antihelminthic Drugs -- Chapter 54: Cancer Chemotherapy -- Chapter 55: Immunopharmacology -- SECTION IX: TOXICOLOGY -- Chapter 56: Introduction to Toxicology: Occupational & Environmental -- Chapter 57: Heavy Metal Intoxication & Chelators -- Chapter 58: Management of the Poisoned Patient -- SECTION X: SPECIAL TOPICS -- Chapter 59: Special Aspects of Perinatal & Pediatric Pharmacology -- Chapter 60: Special Aspects of Geriatric Pharmacology -- Chapter 61: Dermatologic Pharmacology -- Chapter 62: Drugs Used in the Treatment of Gastrointestinal Diseases -- Chapter 63: Therapeutic & Toxic Potential of Over-the-Counter Agents -- Chapter 64: Dietary Supplements & Herbal Medications -- Chapter 65: Rational Prescribing & Prescription Writing -- Chapter 66: Important Drug Interactions & Their Mechanisms -- Appendix: Vaccines, Immune Globulins, & Other Complex Biologic Products.
520 3# - SUMMARY, ETC.
Summary, etc. The fourteenth edition of Basic & Clinical Pharmacology continues the extensive use of full-color illustrations and expanded coverage of transporters, pharmacogenomics, and new drugs of all types emphasized in prior editions. In addition, it reflects the major expansion of large-molecule drugs in the pharmacopeia, with numerous new monoclonal antibodies and other biologic agents. Case studies accompany most chapters, and answers to questions posed in the case studies appear at the end of each chapter. The book is designed to provide a comprehensive, authoritative, and readable pharmacology textbook for students in the health sciences. Frequent revision is necessary to keep pace with the rapid changes in pharmacology and therapeutics; the 2-3 year revision cycle of this text is among the shortest in the field, and the availability of an online version provides even greater currency. The book also offers special features that make it a useful reference for house officers and practicing clinicians.
530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE
Additional physical form available note Also issued in Online and PDF version.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on cover image and table of contents, viewed on Dec. 26, 2017.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical pharmacology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacology
General subdivision Case studies.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacology, Clinical.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical pharmacology.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacology.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacology, Clinical.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Katzung, Bertram G.,
Relator term ed.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Online version:
Title Basic & Clinical Pharmacology.
Edition Fourteenth Edition.
Place, publisher, and date of publication New York, N.Y. : McGraw-Hill Education LLC.,
Qualifying information 2018.
Record control number (OCoLC)1009849139
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title McGraw-Hill's AccessPharmacy.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title A Lange medical book.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://accesspharmacy.mhmedical.com/book.aspx?bookid=2249">http://accesspharmacy.mhmedical.com/book.aspx?bookid=2249</a>

No items available.

Implemented & Customized by: BestBookBuddies

Powered by Koha